Pai Holdings Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PAI HOLDINGS PHARM, and what generic and branded alternatives to PAI HOLDINGS PHARM drugs are available?
PAI HOLDINGS PHARM has forty-six approved drugs.
Drugs and US Patents for Pai Holdings Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pai Holdings Pharm | DICLOFENAC SODIUM | diclofenac sodium | SOLUTION;TOPICAL | 202769-001 | Jul 8, 2015 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Pai Holdings Pharm | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | CAPSULE;ORAL | 065478-002 | Apr 9, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Pai Holdings Pharm | CLOBETASOL PROPIONATE | clobetasol propionate | LOTION;TOPICAL | 208667-001 | Nov 29, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Pai Holdings Pharm | ZINACEF | cefuroxime sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 050558-002 | Oct 19, 1983 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Pai Holdings Pharm | HYDROXYZINE HYDROCHLORIDE | hydroxyzine hydrochloride | SYRUP;ORAL | 040391-001 | Apr 10, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Pai Holdings Pharm | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | SOLUTION;ORAL | 071985-001 | Mar 3, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Pai Holdings Pharm | CEFOTAN | cefotetan disodium | INJECTABLE;INJECTION | 050588-002 | Dec 27, 1985 | AP | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Pai Holdings Pharm
Similar Applicant Names
Here is a list of applicants with similar names.